Stock Scorer

Haemonetics Corp (HAE) · Insider trading

What Haemonetics's directors, officers and largest holders bought and sold themselves, from the Form 4 each of them files with the SEC within two business days of a trade. Open-market purchases and sales first: those are the trades somebody chose to make at the market price.

Bought, 12 months
$98,784
1 insider, 1 trade
Sold, 12 months
$0
0 insiders
Net, 12 months
+$98,784
bought less sold
Latest filing
2026-07-28
filings read to 2026-10-19

Bought and sold at the market, by month

Two years. Purchases above the line, sales below, in dollars.

2025-01 2025-07 2025-11: $98,784 bought 2026-01 2026-07
Bought Sold Largest month: $98,784

Who traded, two years

InsiderBoughtSold TradesLast tradeHolds after
Kroll Mark WDirector $98,784 – 1 2025-11-10 24,757

Open-market purchases and sales

Newest first. “Plan” marks a trade made under a 10b5-1 plan set up in advance.

DateInsiderTradeShares PriceValueHolds afterFiling
2025-11-10 Kroll Mark WDirector Buy 1,400 70.56 $98,784 24,757 Form 4

Grants, exercises and other transactions

Pay, tax and paperwork rather than a choice to trade at the market price. Two years.

36 × grant or award30 × shares withheld for tax
Show them
DateInsiderWhatShares PriceHolds afterFiling
2026-07-24 Abernathy Robert eDirector Grant or award A +2,538 – 27,519 Form 4
2026-07-24 Bryant Diane MDirector Grant or award A +2,538 – 9,664 Form 4
2026-07-24 Coyle Michael JDirector Grant or award A +2,538 – 17,932 Form 4
2026-07-24 Johnson Lloyd EmersonDirector Grant or award A +2,538 – 15,471 Form 4
2026-07-24 Kroll Mark WDirector Grant or award A +2,538 – 27,295 Form 4
2026-07-24 Pomeroy ClaireDirector Grant or award A +2,538 – 19,410 Form 4
2026-07-24 Zane Ellen MDirector Grant or award A +2,538 – 21,911 Form 4
2026-07-24 Madaus Martin DDirector Grant or award A +2,538 – 2,538 Form 4
2026-06-05 Miller Laurie A.SVP, Human Resources Shares withheld for tax F −313 71.28 40,987 Form 4
2026-06-05 Maunsell Farris MaryanneVP, Chief Accounting Officer Shares withheld for tax F −259 71.28 6,242 Form 4
2026-05-15 Simon, ChristopherDirector, President & CEO Shares withheld for tax F −9,681 56.29 366,360 Form 4
2026-05-15 Simon, ChristopherDirector, President & CEO Grant or award A +78,344 – 444,704 Form 4
2026-05-15 Miller Laurie A.SVP, Human Resources Shares withheld for tax F −948 56.29 27,977 Form 4
2026-05-15 Miller Laurie A.SVP, Human Resources Grant or award A +13,323 – 41,300 Form 4
2026-05-15 Galvin RoyEVP, Chief Commercial Officer Shares withheld for tax F −879 56.29 12,347 Form 4
2026-05-15 Galvin RoyEVP, Chief Commercial Officer Grant or award A +27,535 – 39,882 Form 4
2026-05-15 Maunsell Farris MaryanneVP, Chief Accounting Officer Shares withheld for tax F −197 56.29 4,281 Form 4
2026-05-15 Maunsell Farris MaryanneVP, Chief Accounting Officer Grant or award A +2,220 – 6,501 Form 4
2026-05-15 DArecca JamesEVP, Chief Financial Officer Shares withheld for tax F −2,505 56.29 25,132 Form 4
2026-05-15 DArecca JamesEVP, Chief Financial Officer Grant or award A +29,312 – 54,444 Form 4
2026-05-15 Chan FrankEVP, Chief Operating Officer Shares withheld for tax F −546 56.29 5,401 Form 4
2026-05-15 Chan FrankEVP, Chief Operating Officer Grant or award A +27,535 – 32,936 Form 4
2026-05-15 Basil Michelle LEVP and General Counsel Shares withheld for tax F −2,913 56.29 40,405 Form 4
2026-05-15 Basil Michelle LEVP and General Counsel Grant or award A +28,424 – 68,829 Form 4
2026-05-01 DArecca JamesEVP, Chief Financial Officer Shares withheld for tax F −655 59.26 27,637 Form 4
2025-10-31 Galvin RoyEVP, Chief Commercial Officer Shares withheld for tax F −145 50.01 12,811 Form 4
2025-09-17 Miller Laurie A.SVP, Human Resources Shares withheld for tax F −238 49.95 28,925 Form 4
2025-07-24 Abernathy Robert eDirector Grant or award A +2,693 – 24,981 Form 4
2025-07-24 Bryant Diane MDirector Grant or award A +2,693 – 7,126 Form 4
2025-07-24 Coyle Michael JDirector Grant or award A +2,693 – 15,394 Form 4
2025-07-24 Dockendorff Charles JDirector Grant or award A +2,693 – 7,126 Form 4
2025-07-24 Johnson Lloyd EmersonDirector Grant or award A +2,693 – 12,933 Form 4
2025-07-24 Kroll Mark WDirector Grant or award A +2,693 – 23,357 Form 4
2025-07-24 Pomeroy ClaireDirector Grant or award A +2,693 – 16,872 Form 4
2025-07-24 Zane Ellen MDirector Grant or award A +2,693 – 19,373 Form 4
2025-06-05 Maunsell Farris MaryanneVP, Chief Accounting Officer Grant or award A +2,662 – 4,478 Form 4
2025-06-05 Miller Laurie A.SVP, Human Resources Grant or award A +3,195 – 29,163 Form 4
2025-05-30 Basil Michelle LEVP and General Counsel Grant or award A +15,554 – 49,721 Form 4
2025-05-30 Basil Michelle LEVP and General Counsel Shares withheld for tax F −7,469 69.38 42,252 Form 4
2025-05-30 DArecca JamesEVP, Chief Financial Officer Grant or award A +12,221 – 34,156 Form 4
2025-05-30 DArecca JamesEVP, Chief Financial Officer Shares withheld for tax F −5,864 69.38 28,292 Form 4
2025-05-30 Miller Laurie A.SVP, Human Resources Grant or award A +7,777 – 28,251 Form 4
2025-05-30 Miller Laurie A.SVP, Human Resources Shares withheld for tax F −2,283 69.38 25,968 Form 4
2025-05-30 Simon, ChristopherDirector, President & CEO Grant or award A +66,666 – 401,778 Form 4
2025-05-30 Simon, ChristopherDirector, President & CEO Shares withheld for tax F −26,234 69.38 375,544 Form 4
2025-05-16 Galvin RoyEVP, Chief Commercial Officer Grant or award A +5,689 – 12,932 Form 4/A
2025-05-16 Basil Michelle LEVP and General Counsel Grant or award A +6,755 – 35,233 Form 4/A
2025-05-16 Simon, ChristopherDirector, President & CEO Grant or award A +21,405 – 335,112 Form 4
2025-05-16 DArecca JamesEVP, Chief Financial Officer Grant or award A +7,111 – 21,935 Form 4
2025-05-16 Chan FrankEVP, Chief Operating Officer Grant or award A +5,689 – 5,689 Form 4
2025-05-16 Miller Laurie A.SVP, Human Resources Grant or award A +3,200 – 20,474 Form 4
2025-05-16 Maunsell Farris MaryanneVP, Chief Accounting Officer Grant or award A +800 – 1,816 Form 4
2025-05-16 Simon, ChristopherDirector, President & CEO Shares withheld for tax F −7,089 70.31 313,707 Form 4
2025-05-16 Miller Laurie A.SVP, Human Resources Shares withheld for tax F −477 70.31 17,274 Form 4
2025-05-16 Galvin RoyPresident, Global Plasma & BC Shares withheld for tax F −257 70.31 7,243 Form 4
2025-05-16 Maunsell Farris MaryanneVP, Chief Accounting Officer Shares withheld for tax F −68 70.31 1,016 Form 4
2025-05-16 DArecca JamesEVP, Chief Financial Officer Shares withheld for tax F −1,246 70.31 14,824 Form 4
2025-05-16 Basil Michelle LEVP and General Counsel Shares withheld for tax F −2,157 70.31 28,478 Form 4
2025-05-15 Simon, ChristopherDirector, President & CEO Shares withheld for tax F −2,391 69.38 320,796 Form 4
2025-05-15 Miller Laurie A.SVP, Human Resources Shares withheld for tax F −206 69.38 17,751 Form 4
2025-05-15 Galvin RoyPresident, Global Plasma & BC Shares withheld for tax F −201 69.38 7,500 Form 4
2025-05-15 Maunsell Farris MaryanneVP, Chief Accounting Officer Shares withheld for tax F −60 69.38 1,084 Form 4
2025-05-15 DArecca JamesEVP, Chief Financial Officer Shares withheld for tax F −622 69.38 16,070 Form 4
2025-05-15 Basil Michelle LEVP and General Counsel Shares withheld for tax F −622 69.38 30,635 Form 4
2025-05-02 DArecca JamesEVP, Chief Financial Officer Shares withheld for tax F −654 63.85 16,692 Form 4
2024-11-01 Galvin RoyPresident, Global Plasma & BC Shares withheld for tax F −161 71.48 7,373 Form 4

How to read it

Buy, sale
Code P and S on the form: shares bought or sold in the market, at the market price. The other codes are mostly pay (a grant, an option exercised) or tax (shares the company withheld), and say little about what the insider thinks of the price.
Plan
A sale or purchase under a Rule 10b5-1 plan, set up in advance and running on its own schedule. Since April 2023 the form has a box for it. Much executive selling is planned and says more about diversifying than about the company.
Holds after
The shares the insider still held after the trade, in the form the trade was in (directly, or indirectly through a trust or a fund).
Value
Shares times the price the form reports, which is often an average over several fills on the day.

Read from the SEC's own quarterly data sets of Forms 3, 4 and 5, and from each day's filings since the last one. A correcting amendment replaces the lines it restates. Every row links to its filing. None of this is advice: insiders sell for many reasons, and buy for fewer.

Haemonetics's scores and multiples ›